<?xml version="1.0" encoding="UTF-8"?>
<p>COVID‐19 infection is associated with a prothrombotic state causing venous and arterial thrombosis and elevated D‐dimer. The reported incidence of cerebrovascular disease among severe COVID‐19 patients varied from 2.3% to 22%.
 <xref rid="clc23406-bib-0027" ref-type="ref">
  <sup>27</sup>
 </xref>Increased production of antiphospholipid antibodies has been suggested as a possible cause of ischemic stroke.
 <xref rid="clc23406-bib-0028" ref-type="ref">
  <sup>28</sup>
 </xref> Stroke has been found to be associated with a ∼2.5‐fold increased disease severity in patients with COVID‐19.
 <xref rid="clc23406-bib-0027" ref-type="ref">
  <sup>27</sup>
 </xref>
</p>
